Wordt geladen...
Pharmacokinetics of the Long‐Acting Basal Insulin LY2605541 in Subjects With Varying Degrees of Renal Function
The pharmacokinetics of LY2605541 (basal insulin peglispro), a novel long‐acting basal insulin analogue, was evaluated in 5 groups of subjects with varying degrees of renal function based on creatinine clearance: normal renal function (>80 mL/min), mild renal impairment (51–80 mL/min), moderate r...
Bewaard in:
| Gepubliceerd in: | Clin Pharmacol Drug Dev |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5071690/ https://ncbi.nlm.nih.gov/pubmed/27163501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.252 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|